LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
24h
Current
Min
4.26
Max
4.49
Employees | 11 |
---|
Recommendations | Buy |
---|---|
12 Months Forecast | +250.23% upside |
Market Cap | 15M |
---|---|
Previous open | 7.23 |
Previous close | 4.29 |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
11 gru 2024, 18:44 UTC
Cellectar Biosciences Plunges on Pursuit of Strategic Options for Cancer Drug Candidate, 60% Workforce Cut
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 15.2 USD 250.23%
High 18 USD
Low 12.4 USD
Based on 3 Wall Street analysts offering 12 month price targets forCellectar Biosciences Inc - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
1
Buy
2
Hold
0
Sell
Based on 3 analysts giving stock ratings to Cellectar Biosciences Inc - Dist in the past 3 months.
$